tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market
XFOR
X4 Pharmaceuticals
RESEARCH TOOLSreports

X4 Pharmaceuticals (XFOR) Financial Statements

Compare
1,112 Followers

X4 Pharmaceuticals Financial Overview

X4 Pharmaceuticals's market cap is currently $391.86M. The company's EPS TTM is $-0.22; its P/E ratio is -2.14; X4 Pharmaceuticals is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 35.11M$ 2.56M$ 0.00$ 0.00$ 0.00
Gross Profit$ 28.86M$ 1.76M$ 0.00$ 0.00$ -1.89M
Operating Income$ -86.88M$ -36.40M$ -107.52M$ -87.57M$ -75.35M
EBITDA$ -85.61M$ -27.58M$ -94.89M$ -89.33M$ -73.46M
Net Income$ -79.20M$ -37.45M$ -101.17M$ -93.87M$ -88.70M
Balance Sheet
Cash & Short-Term Investments$ 253.00M$ 102.06M$ 114.22M$ 121.72M$ 81.79M
Total Assets$ 290.46M$ 146.45M$ 147.26M$ 155.59M$ 117.18M
Total Debt$ 77.28M$ 78.09M$ 58.28M$ 38.42M$ 39.78M
Net Debt$ -139.76M$ 22.39M$ -40.94M$ -83.30M$ -42.00M
Total Liabilities$ 104.17M$ 124.30M$ 96.16M$ 81.53M$ 52.76M
Stockholders' Equity$ 186.29M$ 22.15M$ 51.10M$ 74.05M$ 64.41M
Cash Flow
Free Cash Flow$ -88.62M$ -138.23M$ -96.57M$ -77.20M$ -71.52M
Operating Cash Flow$ -85.62M$ -130.90M$ -96.51M$ -77.10M$ -70.91M
Investing Cash Flow$ 8.15M$ 66.99M$ -14.88M$ -103.00K$ -615.00K
Financing Cash Flow$ 238.63M$ 20.29M$ 88.52M$ 117.23M$ 74.25M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

Income Statement >

X4 Pharmaceuticals Debt to Assets

Balance Sheet >

X4 Pharmaceuticals Cash Flow

Cash Flow >

X4 Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >